Key metrics and charts across all fundamental categories.
Stock price and market valuation
RGA trades at $210.54, a 6.9% increase year-over-year. Market capitalization stands at $13.69B, up 5.3% from the prior year. Track RGA price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$24.93B in TTM revenue grew 18.6% YoY, reaching $6.49B last quarter. TTM EBITDA of $1.66B on operating income of $441.00M shows growth is flowing through. Net income of $1.23B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $164.06B in assets and $6.11B in long-term debt, the D/E of 0.5 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 11.2x P/E, the stock trades below market averages — potentially undervalued. P/S of 0.5x and P/B of 1.0x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of 6.8% is down 0.2% YoY — costs are rising relative to revenue. Net margin at 5.1%. ROE of 9.2% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $-2.96B on $-2.87B in operating cash flow. The FCF / Net Income ratio of -2.4x shows cash consumption — the business is not yet self-funding. Cash reserves of $4.99B provide financial flexibility.
